Zymeworks据悉接近以9.29亿美元收购Theravance
2026-06-29 09:20:21
据彭博社报道，知情人士称，加拿大温哥华生物科技公司Zymeworks Inc.正就以9.29亿美元收购Theravance Biopharma Inc.进行深入谈判。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
西班牙上调2026年经济增长预测Next article：
恒指期货日盘开盘涨0.82%
